Please provide your email address to receive an email when new articles are posted on . Up to 88% of sentinel lymph node biopsies (SNLB) return with a negative result. The DecisionDx-Melanoma test, ...

The use of artificial intelligence to detect sentinel lymph nodes in patients with breast cancer may be able to save time and reduce costs as compared with immunohistochemistry. Artificial ...

Please provide your email address to receive an email when new articles are posted on . Sentinel lymph node biopsy was effective as a prognostic and staging tool in stage IIB/C melanoma, according to ...

Sentinel lymph node biopsy has replaced traditional axillary dissection, minimizing lymphedema risk in breast cancer surgery. The procedure targets the first draining lymph nodes, reducing unnecessary ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...

The Melanoma Institute of Australia (MIA) previously developed a risk calculator for sentinel lymph node (SLN) metastasis risk to help clinicians and patients with primary cutaneous melanoma decide ...

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen treatment burdens. University of Pittsburgh and UPMC Hillman Cancer Center ...

SAN ANTONIO -- Patients with early breast cancer who skipped axillary lymph node dissection (ALND) lived just as long as those who underwent sentinel lymph node biopsy (SLNB), the randomized INSEMA ...

IntroductionLymph node involvement significantly impacts the prognosis of patients with gynecologic cancers, such as vulvar and cervical cancers. Traditional extensive lymph node dissection is ...

Slightly more women 70 years or older with these early breast cancers had chemo-qualifying Oncotype DX 21-gene recurrence scores (>26) if node positive than if node ...